These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
223 related articles for article (PubMed ID: 24530743)
1. Substantial gaps in knowledge of Bordetella pertussis antibody and T cell epitopes relevant for natural immunity and vaccine efficacy. Vaughan K; Seymour E; Peters B; Sette A Hum Immunol; 2014 May; 75(5):440-51. PubMed ID: 24530743 [TBL] [Abstract][Full Text] [Related]
2. Development and Validation of a da Silva Antunes R; Quiambao LG; Sutherland A; Soldevila F; Dhanda SK; Armstrong SK; Brickman TJ; Merkel T; Peters B; Sette A J Immunol Res; 2020; 2020():8202067. PubMed ID: 32322598 [TBL] [Abstract][Full Text] [Related]
3. Loss of multi-epitope specificity in memory CD4(+) T cell responses to B. pertussis with age. Han WG; van Twillert I; Poelen MC; Helm K; van de Kassteele J; Verheij TJ; Versteegh FG; Boog CJ; van Els CA PLoS One; 2013; 8(12):e83583. PubMed ID: 24391789 [TBL] [Abstract][Full Text] [Related]
4. Epitope structure of the Bordetella pertussis protein P.69 pertactin, a major vaccine component and protective antigen. Hijnen M; Mooi FR; van Gageldonk PG; Hoogerhout P; King AJ; Berbers GA Infect Immun; 2004 Jul; 72(7):3716-23. PubMed ID: 15213111 [TBL] [Abstract][Full Text] [Related]
5. Antigenic analysis of Bordetella pertussis filamentous hemagglutinin with phage display libraries and rabbit anti-filamentous hemagglutinin polyclonal antibodies. Wilson DR; Siebers A; Finlay BB Infect Immun; 1998 Oct; 66(10):4884-94. PubMed ID: 9746593 [TBL] [Abstract][Full Text] [Related]
6. Antibody Specificity Following a Recent Raeven RHM; van der Maas L; Pennings JLA; Fuursted K; Jørgensen CS; van Riet E; Metz B; Kersten GFA; Dalby T Front Immunol; 2019; 10():1364. PubMed ID: 31275314 [No Abstract] [Full Text] [Related]
7. [An acellular pertussis vaccine based on the natural complex of antigens isolated from the supernatant of a synthetic culture medium]. Zakharova NS; Remova TN; Bazhanova IG; Ozeretskovskaia MH; Britsina MV; Shmeleva EI; Mertsalova NU; Ermolova EI; Sukhinova EE; Bulk VF; Sirotinskiĭ AV; Poluiianova AG; Sviridov VV; Vartanian IuP Zh Mikrobiol Epidemiol Immunobiol; 1997; (3):67-70. PubMed ID: 9304334 [TBL] [Abstract][Full Text] [Related]
8. Epitope mapping the Fim2 and Fim3 proteins of Bordetella pertussis with sera from patients infected with or vaccinated against whooping cough. Williamson P; Matthews R FEMS Immunol Med Microbiol; 1996 Feb; 13(2):169-78. PubMed ID: 8731026 [TBL] [Abstract][Full Text] [Related]
9. Mouse and pig models for studies of natural and vaccine-induced immunity to Bordetella pertussis. Mills KH; Gerdts V J Infect Dis; 2014 Apr; 209 Suppl 1():S16-9. PubMed ID: 24626866 [TBL] [Abstract][Full Text] [Related]
10. Bordetella Pertussis virulence factors in the continuing evolution of whooping cough vaccines for improved performance. Dorji D; Mooi F; Yantorno O; Deora R; Graham RM; Mukkur TK Med Microbiol Immunol; 2018 Feb; 207(1):3-26. PubMed ID: 29164393 [TBL] [Abstract][Full Text] [Related]
11. Roads to the development of improved pertussis vaccines paved by immunology. Brummelman J; Wilk MM; Han WG; van Els CA; Mills KH Pathog Dis; 2015 Nov; 73(8):ftv067. PubMed ID: 26347400 [TBL] [Abstract][Full Text] [Related]
13. Different T cell memory in preadolescents after whole-cell or acellular pertussis vaccination. Smits K; Pottier G; Smet J; Dirix V; Vermeulen F; De Schutter I; Carollo M; Locht C; Ausiello CM; Mascart F Vaccine; 2013 Dec; 32(1):111-8. PubMed ID: 24176499 [TBL] [Abstract][Full Text] [Related]
14. Development of vaccines against pertussis caused by Bordetella holmesii using a mouse intranasal challenge model. Saito M; Odanaka K; Otsuka N; Kamachi K; Watanabe M Microbiol Immunol; 2016 Sep; 60(9):599-608. PubMed ID: 27515393 [TBL] [Abstract][Full Text] [Related]
15. Serologic response and antibody-titer decay in adults with pertussis. Heininger U; Cherry JD; Stehr K Clin Infect Dis; 2004 Feb; 38(4):591-4. PubMed ID: 14765356 [TBL] [Abstract][Full Text] [Related]
16. A controlled trial of two acellular vaccines and one whole-cell vaccine against pertussis. Progetto Pertosse Working Group. Greco D; Salmaso S; Mastrantonio P; Giuliano M; Tozzi AE; Anemona A; Ciofi degli Atti ML; Giammanco A; Panei P; Blackwelder WC; Klein DL; Wassilak SG N Engl J Med; 1996 Feb; 334(6):341-8. PubMed ID: 8538704 [TBL] [Abstract][Full Text] [Related]
17. Identification of linear B epitopes of pertactin of Bordetella pertussis induced by immunization with whole and acellular vaccine. da Silva FR; Napoleão-Pego P; De-Simone SG Vaccine; 2014 Oct; 32(47):6251-8. PubMed ID: 25252193 [TBL] [Abstract][Full Text] [Related]
18. Immunologic and epidemiologic experience of vaccination with a monocomponent pertussis toxoid vaccine. Taranger J; Trollfors B; Bergfors E; Knutsson N; Lagergård T; Schneerson R; Robbins JB Pediatrics; 2001 Dec; 108(6):E115. PubMed ID: 11731642 [TBL] [Abstract][Full Text] [Related]
19. [Acellular pertussis vaccine]. Wiedermann G; Ambrosch F; Vanura H Wien Med Wochenschr; 1991; 141(12):270-2. PubMed ID: 1949820 [TBL] [Abstract][Full Text] [Related]
20. A search for serologic correlates of immunity to Bordetella pertussis cough illnesses. Cherry JD; Gornbein J; Heininger U; Stehr K Vaccine; 1998 Dec; 16(20):1901-6. PubMed ID: 9796041 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]